Internal Medicine, Nephrology · New York, NY
NPI
1972579530
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
323 E 34th St Fl 2
New York, NY, 10016
Phone (212) 263-5654
Groups this clinician bills Medicare through
Medicare paid, 2024
$154K
1,088 services
Medicare patients, 2024
239
Average age 75
Drug cost, 2024
$407K
2,582 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Matalon was code 99213 (office e&m - established), 209 times for 113 patients. In total Daniel Matalon billed 1,088 services in 18 codes, and Medicare paid $154K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 209 | 113 | $75.98 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 186 | 42 | $68.30 | $13K |
| 90960 ESRD Related Services (not dialysis) | Office | 174 | 23 | $305.48 | $53K |
| 99233 Hospital E&M - Subsequent | Facility | 148 | 33 | $102.71 | $15K |
| 99214 Office E&M - Established | Office | 112 | 73 | $109.69 | $12K |
| 99291 Critical Care E&M | Facility | 52 | 20 | $184.53 | $9,595 |
| 99215 Office E&M - Established | Office | 51 | 32 | $159.40 | $8,130 |
| 99205 Office E&M - New | Office | 45 | 45 | $178.08 | $8,014 |
| 99223 Hospital E&M - Initial | Facility | 33 | 22 | $149.99 | $4,950 |
| 99212 Office E&M - Established | Office | 16 | 14 | $47.74 | $764 |
By year: 2022 $139K for 838 services; 2023 $162K for 1,070 services; 2024 $154K for 1,088 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Matalon prescribed most often to Medicare patients was Torsemide, with 151 prescriptions and refills. In total Daniel Matalon wrote 2,582 Medicare prescriptions that cost $407K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Torsemide Generic | 151 | 263 | 30 | $969 |
| Amlodipine Besylate Generic | 146 | 286 | 40 | $658 |
| Sevelamer Carbonate Generic | 140 | 181 | 35 | $18K |
| Valsartan Generic | 135 | 233 | 27 | $1,368 |
| Clinolipid Fat Emulsion/Olive/Soy/Phospho | 132 | 132 | Under 11 | $30K |
| Atorvastatin Calcium Generic | 113 | 244 | 29 | $1,118 |
| Calcitriol Generic | 102 | 177 | 23 | $1,067 |
| Allopurinol Generic | 99 | 222 | 26 | $855 |
| Hydralazine Hcl Generic | 87 | 121 | 23 | $619 |
| Hydrochlorothiazide Generic | 72 | 150 | 17 | $359 |
| Losartan Potassium Generic | 71 | 150 | 18 | $664 |
| Calcium Acetate Generic | 67 | 73 | 19 | $2,713 |
| Furosemide Generic | 65 | 103 | 13 | $289 |
| Metoprolol Succinate Generic | 64 | 104 | 13 | $841 |
| Jardiance Empagliflozin | 56 | 68 | 11 | $39K |
Brand drugs: - claims; generic drugs: 2,125 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Daniel Matalon were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.